NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/10/2022
Voltar para busca
Dado oficial do USPTO
NOVORIG
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
45
Atualização mais recente
04/10/2022
Tipo de marca
Verbal
Classes Nice
42
Data de depósito
13/08/2020
Data de registro
04/10/2022
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
04/10/2022
Última transação
04/10/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Primeiro uso
28/05/2020
Primeiro uso no comércio
28/05/2020
Código do desenho
4
Tipo de titular
03
Localização do titular
Kitchener, Ontario, CA
Examinador
CUMMINS, LANCE
Unidade examinadora
N20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Rapid Novor Inc.
Representantes
Jeffrey B. Sladkus, Esq. The Sladkus Law Group
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Development of new technology for others in the field of biotechnology; Proteomics analysis services for scientific research purposes; Antibody profiling for scientific research purposes; Laboratory research in the field of immune sequencing; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of immune sequencing; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals; Medical research and medical research analysis in the field of medicine; Research and development in the pharmaceutical and biotechnology fields; Researchdevelopmentengineering and testing services in the fields of immunopharmaceuticals and vaccines; Medical laboratory services
Publicações
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
04/10/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/07/2022
PUBO
PUBLISHED FOR OPPOSITION
19/07/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/06/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/06/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/06/2022
ALIE
ASSIGNED TO LIE
15/06/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
13/06/2022
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
02/06/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/06/2022
GNSL
LETTER OF SUSPENSION E-MAILED
01/06/2022
CNSL
SUSPENSION LETTER WRITTEN
01/06/2022
IUAA
USE AMENDMENT ACCEPTED
01/06/2022
DPCC
DIVISIONAL PROCESSING COMPLETE
31/05/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
31/05/2022
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
03/05/2022
IUAF
USE AMENDMENT FILED
03/05/2022
DRRR
DIVISIONAL REQUEST RECEIVED
03/05/2022
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
03/05/2022
EAAU
TEAS AMENDMENT OF USE RECEIVED
03/05/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/05/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
05/11/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
05/11/2021
CNSI
SUSPENSION INQUIRY WRITTEN
05/11/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/05/2021
GNSL
LETTER OF SUSPENSION E-MAILED
05/05/2021
CNSL
SUSPENSION LETTER WRITTEN
05/05/2021
DOCK
ASSIGNED TO EXAMINER
12/04/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/03/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/03/2021
ALIE
ASSIGNED TO LIE
18/03/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/12/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
14/12/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/12/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
14/12/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/12/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/12/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
14/12/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/12/2020
GNRT
NON-FINAL ACTION E-MAILED
08/12/2020
CNRT
NON-FINAL ACTION WRITTEN
08/12/2020
DOCK
ASSIGNED TO EXAMINER
08/12/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/09/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NOVORIG ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.